Highline Wealth Partners
ELV icon

Highline Wealth Partners’s Elevance Health ELV Stock Holding History

Highline Wealth Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.9K Buy
69
+10
+17% +$3.99K 0.01% 374
2026
Q2 		$22.9K Buy
59
+13
+28% +$4.82K ﹤0.01% 369
2026
Q1 		$13.5K Buy
46
+20
+77% +$6.57K ﹤0.01% 382
2025
Q4 		$9.15K Sell
26
-5
-16% -$1.69K ﹤0.01% 420
2025
Q3 		$10K Buy
31
+20
+182% +$6.22K ﹤0.01% 413
2025
Q2 		$4.3K Sell
11
-13
-54% -$5.23K ﹤0.01% 479
2025
Q1 		$10.5K Buy
24
+14
+140% +$5.62K ﹤0.01% 303
2024
Q4 		$3.7K Buy
10
+5
+100% +$2.09K ﹤0.01% 384
2024
Q3 		$2.61K Buy
5
+1
+25% +$534 ﹤0.01% 430
2024
Q2 		$2.17K Hold
4
– – ﹤0.01% 384
2024
Q1 		$2.07K Hold
4
– – ﹤0.01% 327
2023
Q4 		$1.89K Sell
4
-22
-85% -$10.2K ﹤0.01% 304
2023
Q3 		$11.3K Buy
26
+22
+550% +$10K 0.01% 177
2023
Q2 		$1.78K Sell
4
-1
-20% -$461 ﹤0.01% 236
2023
Q1 		$2.3K Buy
5
+1
+25% +$476 ﹤0.01% 221
2022
Q4 		$2.05K Hold
4
– – ﹤0.01% 219
2022
Q3 		$1.82K Buy
+4
New +$1.91K ﹤0.01% 217

Other funds holding ELV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Highline Wealth Partners's ELV Position: Q3 2026 in Review

Highline Wealth Partners increased its Elevance Health (ELV) stake by 17% in Q3 2026, buying an estimated $3.99K and bringing the position to 69 shares worth $26.9K. The position accounts for 0.01% of the portfolio, ranked #374.

Highline Wealth Partners first reported a position in ELV in Q3 2022 and has held it in 17 quarters since. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Highline Wealth Partners held 69 shares of Elevance Health worth $26.9K as of Q3 2026.
  • Highline Wealth Partners bought 10 Elevance Health shares in Q3 2026, an estimated $3.99K.
  • Elevance Health made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #374 holding.
  • Highline Wealth Partners first reported a position in Elevance Health in Q3 2022 and has held it in 17 quarters since.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.